NCT07602010
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Oslo University Hospital Oslo, Norway
Clinical trial condition
Muscle Invasive Bladder Cancer (MIBC)
Explore clinical trials studying Muscle Invasive Bladder Cancer (MIBC). Study availability and eligibility vary by location and protocol.
7 public trials
4 recruiting studies
Muscle Invasive Bladder Cancer (MIBC) trial results
NCT07296705
- Conditions
- Muscle Invasive Bladder Cancer (MIBC)
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Fujian Provincial Hospital Affiliated to Fuzhou University Fuzhou, Fujian, China
- Affiliated Hospital of Putian University Putian, Fujian, China
- Quanzhou First Hospital Affiliated to Fujian Medical University Quanzhou, Fujian, China
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Australia
- UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
- Centre Jean Perrin Clermont-Ferrand, France
- Centre Georges François Leclerc Dijon, France
Recruiting
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
NCT07067749
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy, Bladder Carcinoma, +13 more
- Locations
-
- Policlinico Tor Vergata Rome, RM, Italy
Not Yet Recruiting
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
NCT07474064
- Conditions
- Muscle Invasive Bladder Cancer (MIBC)
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
NCT07201675
- Conditions
- Muscle Invasive Bladder Cancer (MIBC)
- Locations
-
Not specified
Not Yet Recruiting
MRI-Guided Bladder Preservation Program For Patients With Muscle Invasive Bladder Cancer
NCT07026864
- Conditions
- Muscle Invasive Bladder Cancer (MIBC)
- Locations
-
Not specified